Big Molecule Watch
- European Commission Approves Celltrion’s AVTOZMA (CT-P47) March 3, 2025 Timothy Beavers
- FDA Accepts U.S. Biologics License Application for AVT06, Alvotech and Teva’s Proposed Aflibercept Biosimilar February 24, 2025 Allegra Padula
- FDA Approves First Rapid-Acting Insulin Biosimilar Product for the Treatment of Diabetes February 19, 2025 Allegra Padula
- IP Litigator Publishes Goodwin Partners’ BPCIA Research February 18, 2025 Sarah Clarke
- UK’s MHRA Grants Marketing Authorization for Chikungunya Vaccine February 17, 2025 Sam Herron
- Regulatory Updates on Samsung’s Denosumab Biosimilars February 17, 2025 Riley Wyberg
- Dr. Reddy’s Secures License from Henlius to Market Daratumumab Biosimilar in the U.S. and Europe February 14, 2025 Emma Murray
- Regulatory and Commercial Updates on Bio-Thera’s BAT2506 (golimumab) February 11, 2025 Riley Wyberg
- HyClone Seeks to Quash Amgen’s Subpoena Issued in Denosumab BPCIA Litigation Against Fresenius February 10, 2025 Allegra Padula
- EU Biosimilar Regulatory and Launch Updates February 7, 2025 Zachariah Holmes